PAR 0.00% 30.0¢ paradigm biopharmaceuticals limited..

The realisation of ongoing P3 costs may be why we're indirectly...

  1. 9,762 Posts.
    lightbulb Created with Sketch. 1234
    The realisation of ongoing P3 costs may be why we're indirectly hearing about "forward sale royalties"

    Not convinced its all over just yet in terms of funding options available rather there is elevated risks we don't get it on terms we had previous hoped.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $104.9M
Open High Low Value Volume
30.0¢ 31.0¢ 29.5¢ $89.62K 294.9K

Buyers (Bids)

No. Vol. Price($)
3 20607 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 16773 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.